These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 18186116

  • 21. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, Dichgans J, Klockgether T.
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [Abstract] [Full Text] [Related]

  • 22. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC, Paraskevas GP, Stamboulis E, Kapaki E.
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [Abstract] [Full Text] [Related]

  • 23. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
    Ko JH, Lee CS, Eidelberg D.
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
    [Abstract] [Full Text] [Related]

  • 24. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM, Srulijes K, Gröger A, Maetzler W, Berg D.
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    Kwon KY, Choi CG, Kim JS, Lee MC, Chung SJ.
    Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
    [Abstract] [Full Text] [Related]

  • 26. PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
    Perez-Soriano A, Arena JE, Dinelle K, Miao Q, McKenzie J, Neilson N, Puschmann A, Schaffer P, Shinotoh H, Smith-Forrester J, Shahinfard E, Vafai N, Wile D, Wszolek Z, Higuchi M, Sossi V, Stoessl AJ.
    Mov Disord; 2017 Jul; 32(7):1016-1024. PubMed ID: 28568506
    [Abstract] [Full Text] [Related]

  • 27. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
    Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S, Eidelberg D.
    Mov Disord; 2007 Jan 15; 22(2):167-73. PubMed ID: 17133454
    [Abstract] [Full Text] [Related]

  • 28. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K.
    Intern Med; 2011 Jan 15; 50(22):2775-81. PubMed ID: 22082889
    [Abstract] [Full Text] [Related]

  • 29. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K, Imabayashi E, Tokumaru AM, Ito K, Shimoji K, Nakagawa M, Ozawa Y, Shimohira M, Ogawa M, Morimoto S, Aiba I, Matsukawa N, Shibamoto Y.
    Magn Reson Med Sci; 2017 Jan 10; 16(1):16-22. PubMed ID: 27001391
    [Abstract] [Full Text] [Related]

  • 30. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F, Barron DS, Tantiwongkosi B, Fox P.
    Brain Behav; 2015 Jun 10; 5(6):e00329. PubMed ID: 26085961
    [Abstract] [Full Text] [Related]

  • 31. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S, Frings L, Amtage F, Buchert R, Spehl TS, Rijntjes M, Tüscher O, Weiller C, Weber WA, Vach W, Meyer PT.
    J Nucl Med; 2015 Oct 10; 56(10):1541-6. PubMed ID: 26229141
    [Abstract] [Full Text] [Related]

  • 32. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC, Thornton JS, Lees AJ, Jäger HR.
    Mov Disord; 2007 Jan 10; 22(1):68-74. PubMed ID: 17089396
    [Abstract] [Full Text] [Related]

  • 33. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
    Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA.
    Neuroimage; 2004 Jan 10; 21(1):229-35. PubMed ID: 14741660
    [Abstract] [Full Text] [Related]

  • 34. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
    Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G.
    Neuroimage; 1999 Aug 10; 10(2):149-62. PubMed ID: 10417247
    [Abstract] [Full Text] [Related]

  • 35. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
    Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, Chervin RD, Consens F, Bhaumik A.
    Neurology; 2010 May 04; 74(18):1416-23. PubMed ID: 20439843
    [Abstract] [Full Text] [Related]

  • 36. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K, Ishii K, Sakamoto S, Mori T, Sasaki M, Hirono N, Mori E.
    J Neurol Sci; 2002 Jul 15; 199(1-2):67-71. PubMed ID: 12084445
    [Abstract] [Full Text] [Related]

  • 37. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 15; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 38. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H, Granberg T, Westman E, Svenningsson P.
    Parkinsonism Relat Disord; 2017 Nov 15; 44():51-57. PubMed ID: 28886909
    [Abstract] [Full Text] [Related]

  • 39. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L, Kassubek J, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Pinkhardt EH, Respondek G, Stamelou M, Möller F, Schnitzler A, Oertel WH, Knake S, Huppertz HJ, Höglinger GU.
    Mov Disord; 2017 May 15; 32(5):778-782. PubMed ID: 28150443
    [Abstract] [Full Text] [Related]

  • 40. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK.
    J Neurol; 2013 Aug 15; 260(8):2094-101. PubMed ID: 23670309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.